MedTrace Logo

A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China

NCT05445544 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2023-02-08

No results posted yet for this study

Summary

major objective This multicenter, prospective cohort study aims at evaluating the predictive value of microbiome ,proteomics and serum markers in preeclampsia. secondary objective to evaluate the value of microbiome,proteomics and serum markers in assessing pregnancy outcome (complications during pregnancy and delivery, delivery) and neonatal prognosis.

Conditions

Interventions

OTHER

Observational studies, The diagnosis was preeclampsia

Observational studies, The diagnosis was preeclampsia

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Tianjin Central Hospital of Gynecology Obstetrics

    collaborator OTHER

  • Foshan Women's and Children's Hospital

    collaborator OTHER

  • Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    collaborator OTHER

  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • hongwei zhou · Zhujiang Hospital

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05445544 on ClinicalTrials.gov